Showing 121 - 140 results of 112,941 for search '(( i non decrease ) OR ( 5 ((nn decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126

    Data_Sheet_1_Effectiveness of non-pharmaceutical interventions in nine fields of activity to decrease SARS-CoV-2 transmission (Spain, September 2020–May 2021).PDF by Inés Barbeito (5864351)

    Published 2023
    “…In a reduced model with seven fields, culture and leisure no longer had a significant effect while ceremonies decreased transmission by 5% (0.95; 0, 0.96). …”
  7. 127
  8. 128
  9. 129

    Influenza virus infection decreases CLEC7A (Dectin1) mRNA and reduces phagocytosis of zymosan by AM. by Jieru Wang (179734)

    Published 2012
    “…<p>Panel A. Human AM were cultured and infected by PR/8 at a MOI of 0.5. …”
  10. 130

    <i>tra</i> regulates growth in a cell-autonomous, and a non cell-autonomous manner. by Elizabeth J. Rideout (651946)

    Published 2016
    “…(D) Expression of a <i>tra2-RNAi</i> transgene in the posterior compartment of the wing using <i>en-GAL4</i> caused a significant reduction in the ratio of posterior:anterior (p = 1.5 x 10<sup>−6</sup>; Student’s t-test). …”
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137

    Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial by Seyyed Abbas Zojaji (5208589)

    Published 2022
    “…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”
  18. 138

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  19. 139
  20. 140

    CD8+ T-cell interferon-gamma production and proliferation is decreased in <i>T</i>. <i>gondii</i>-infected HD mice. by David W. Donley (3111198)

    Published 2016
    “…<p>HD and wild-type mice were injected ip with 100 <i>T</i>. <i>gondii</i> bradyzoites or vehicle at 5-weeks of age and sacrificed at 15 dpi. …”